Commerzbank Aktiengesellschaft Regeneron Pharmaceuticals, Inc. Transaction History

Commerzbank Aktiengesellschaft

$3.75 Billion
Q3 2024

A detailed history of Commerzbank Aktiengesellschaft transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Commerzbank Aktiengesellschaft holds 402 shares of REGN stock, worth $286,384. This represents 0.01% of its overall portfolio holdings.

Number of Shares

402

Previous 231 74.03%

Holding current value

$286,384

Previous $243,000 74.07%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$1024.09 - $1201.76 $175,119 - $205,500	171 Added 74.03%	402 $423,000
Q2 2024 Jul 22, 2024	BUY	$883.2 - $1071.19 $204,019 - $247,444	231 New	231 $243,000
Q2 2020 Jul 21, 2020	SELL	$493.32 - $643.92 $3.1 Million - $4.05 Million	-6,287 Closed	0 $0
Q1 2020 Oct 03, 2024	BUY	$336.18 - $494.43 $2.04 Million - $2.99 Million	6,056 Added 2621.65%	6,287 $3.07 Million
Q1 2020 Apr 29, 2020	SELL	$336.18 - $494.43 $1.15 Million - $1.7 Million	-3,435 Reduced 35.33%	6,287 $3.07 Million
Q4 2019 Oct 03, 2024	BUY	$274.13 - $376.51 $2.6 Million - $3.57 Million	9,491 Added 4108.66%	9,722 $3.65 Million
Q4 2019 Jan 17, 2020	SELL	$274.13 - $376.51 $5.48 Million - $7.53 Million	-19,989 Reduced 67.28%	9,722 $3.65 Million
Q3 2019 Oct 03, 2024	BUY	$273.46 - $318.39 $8.06 Million - $9.39 Million	29,480 Added 12761.9%	29,711 $8.24 Million
Q3 2019 Oct 17, 2019	BUY	$273.46 - $318.39 $734,240 - $854,877	2,685 Added 9.93%	29,711 $8.24 Million
Q2 2019 Oct 03, 2024	BUY	$299.6 - $414.82 $8.03 Million - $11.1 Million	26,795 Added 11599.57%	27,026 $8.46 Million
Q2 2019 Jul 23, 2019	SELL	$299.6 - $414.82 $1.14 Million - $1.58 Million	-3,808 Reduced 12.35%	27,026 $8.46 Million
Q1 2019 Oct 03, 2024	BUY	$372.08 - $439.57 $11.4 Million - $13.5 Million	30,603 Added 13248.05%	30,834 $12.7 Million
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $1.07 Million - $1.27 Million	2,880 Added 10.3%	30,834 $12.7 Million
Q4 2018 Oct 03, 2024	BUY	$335.82 - $403.04 $9.31 Million - $11.2 Million	27,723 Added 12001.3%	27,954 $10.4 Million
Q4 2018 Feb 06, 2019	BUY	$335.82 - $403.04 $134,328 - $161,216	400 Added 1.45%	27,954 $10.4 Million
Q3 2018 Oct 04, 2024	BUY	$351.14 - $408.51 $9.59 Million - $11.2 Million	27,323 Added 11828.14%	27,554 $11.1 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $4.14 Million - $4.81 Million	11,776 Added 74.64%	27,554 $11.1 Million
Q2 2018 Oct 04, 2024	BUY	$284.6 - $344.99 $4.42 Million - $5.36 Million	15,547 Added 6730.3%	15,778 $5.44 Million
Q2 2018 Aug 10, 2018	SELL	$284.6 - $344.99 $6.79 Million - $8.24 Million	-23,873 Reduced 60.21%	15,778 $5.44 Million
Q1 2018 Oct 04, 2024	BUY	$315.82 - $393.78 $1.06 Million - $1.32 Million	3,363 Added 9.27%	39,651 $13.7 Million
Q1 2018 May 01, 2018	BUY	$315.82 - $393.78 $1.06 Million - $1.32 Million	3,363 Added 9.27%	39,651 $13.7 Million
Q4 2017 Oct 04, 2024	BUY	$358.63 - $469.95 $12.9 Million - $16.9 Million	36,057 Added 15609.09%	36,288 $13.6 Million
Q4 2017 Jan 26, 2018	SELL	$358.63 - $469.95 $2.03 Million - $2.66 Million	-5,656 Reduced 13.48%	36,288 $13.6 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $6.64 Million - $7.76 Million	15,395 Added 57.99%	41,944 $18.8 Million
Q2 2017 Aug 09, 2017	BUY	N/A	26,549	26,549 $13 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.

Account

Commerzbank Aktiengesellschaft Regeneron Pharmaceuticals, Inc. Transaction History